249 related articles for article (PubMed ID: 33715230)
21. GLUT1 regulates cell glycolysis and proliferation in prostate cancer.
Xiao H; Wang J; Yan W; Cui Y; Chen Z; Gao X; Wen X; Chen J
Prostate; 2018 Feb; 78(2):86-94. PubMed ID: 29105798
[TBL] [Abstract][Full Text] [Related]
22. Synergistic Antitumor Effect of Sorafenib in Combination with ATM Inhibitor in Hepatocellular Carcinoma Cells.
Liu J; Liu Y; Meng L; Ji B; Yang D
Int J Med Sci; 2017; 14(6):523-529. PubMed ID: 28638267
[No Abstract] [Full Text] [Related]
23. Synergistic targeting of TrxR1 and ATM/AKT pathway in human colon cancer cells.
Shen X; Xia Y; Lu H; Zheng P; Wang J; Chen Y; Xu C; Qiu C; Zhang Y; Xiao Z; Zou P; Cui R; Ni D
Biomed Pharmacother; 2024 May; 174():116507. PubMed ID: 38565059
[TBL] [Abstract][Full Text] [Related]
24. Effects of chronic Akt activation on glucose uptake in the heart.
Matsui T; Nagoshi T; Hong EG; Luptak I; Hartil K; Li L; Gorovits N; Charron MJ; Kim JK; Tian R; Rosenzweig A
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E789-97. PubMed ID: 16352665
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
Hong SY; Yu FX; Luo Y; Hagen T
Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
[TBL] [Abstract][Full Text] [Related]
26. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
[TBL] [Abstract][Full Text] [Related]
27. RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma.
Yang Q; Lin W; Liu Z; Zhu J; Huang N; Cui Z; Han Z; Pan Q; Goel A; Sun F
Cell Death Dis; 2018 Feb; 9(2):146. PubMed ID: 29396516
[TBL] [Abstract][Full Text] [Related]
28. Ataxia-telangiectasia mutated (ATM) participates in the regulation of ionizing radiation-induced cell death via MAPK14 in lung cancer H1299 cells.
Liang N; Zhong R; Hou X; Zhao G; Ma S; Cheng G; Liu X
Cell Prolif; 2015 Oct; 48(5):561-72. PubMed ID: 26269117
[TBL] [Abstract][Full Text] [Related]
29. Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.
Kim H; Ju JH; Son S; Shin I
FEBS Lett; 2020 Mar; 594(6):1021-1035. PubMed ID: 31736063
[TBL] [Abstract][Full Text] [Related]
30. KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.
Li H; Lan J; Wang G; Guo K; Han C; Li X; Hu J; Cao Z; Luo X
J Exp Clin Cancer Res; 2020 Jan; 39(1):12. PubMed ID: 31931846
[TBL] [Abstract][Full Text] [Related]
31. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
32. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking.
Wieman HL; Wofford JA; Rathmell JC
Mol Biol Cell; 2007 Apr; 18(4):1437-46. PubMed ID: 17301289
[TBL] [Abstract][Full Text] [Related]
33. MiR-203a-3p regulates the biological behaviors of ovarian cancer cells through mediating the Akt/GSK-3β/Snail signaling pathway by targeting ATM.
Liu HY; Zhang YY; Zhu BL; Feng FZ; Zhang HT; Yan H; Zhou B
J Ovarian Res; 2019 Jul; 12(1):60. PubMed ID: 31277702
[TBL] [Abstract][Full Text] [Related]
34. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C
Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674
[TBL] [Abstract][Full Text] [Related]
35. The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent.
Silva C; Andrade N; Guimarães JT; Patrício E; Martel F
Eur J Pharmacol; 2021 May; 898():173980. PubMed ID: 33647254
[TBL] [Abstract][Full Text] [Related]
36. Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells.
Jóźwiak P; Krześlak A; Bryś M; Lipińska A
Oncol Rep; 2015 Feb; 33(2):913-20. PubMed ID: 25502934
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells.
Korwek Z; Sewastianik T; Bielak-Zmijewska A; Mosieniak G; Alster O; Moreno-Villanueva M; Burkle A; Sikora E
DNA Repair (Amst); 2012 Nov; 11(11):864-73. PubMed ID: 23058634
[TBL] [Abstract][Full Text] [Related]
38. ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin.
Li K; Yan H; Guo W; Tang M; Zhao X; Tong A; Peng Y; Li Q; Yuan Z
Exp Cell Res; 2018 May; 366(1):24-33. PubMed ID: 29522753
[TBL] [Abstract][Full Text] [Related]
39. Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells.
Yoon JY; Ishdorj G; Graham BA; Johnston JB; Gibson SB
Apoptosis; 2014 Jan; 19(1):191-200. PubMed ID: 24057147
[TBL] [Abstract][Full Text] [Related]
40. Arginine ADP-ribosyltransferase 1 Regulates Glycolysis in Colorectal Cancer via the PI3K/AKT/HIF1α Pathway.
Long WB; Pu X; Tang Y; Li M; Liu Y; She Q; Wang YL; Guo QX
Curr Med Sci; 2022 Aug; 42(4):733-741. PubMed ID: 35798928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
